Informatie:
Fout:
ID
25950
Beschrijving
Concomitant Medication Ropinirole Case Report Form GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Trefwoorden
Versies (1)
- 01-10-17 01-10-17 -
Houder van rechten
gsk
Geüploaded op
1 oktober 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Concomitant Medication Ropinirole Case Report Form GSK RRL100013
Concomitant Medication Ropinirole Case Report Form GSK RRL100013
- StudyEvent: ODM
Similar models
Concomitant Medication Ropinirole Case Report Form GSK RRL100013
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Concomitant Medication
Item
Are there any concomitant medication changes since the start of the study?
boolean
C2347852 (UMLS CUI [1])
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Single dose
Item
Single dose/Unit
integer
C1960417 (UMLS CUI [1])
Frequency of this dose
Item
Frequency of this dose
integer
C2826654 (UMLS CUI [1])
Drug Administration Routes
Item
Drug Administration Routes
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Start Date and Time
Item
Start Date/Time
datetime
C3897500 (UMLS CUI [1])
End Date and Time
Item
End Date/Time
datetime
C3899266 (UMLS CUI [1])